Font Size:
a
A
A
Keyword [prognostic marker]
Result: 21 - 40 | Page: 2 of 3
21.
Paper One:Discordance Of PD-L1 Expression Between Primary And Recurrent Triple-negative Breast Carcinoma Has A Prognostic Impact Paper Two:Thioredoxin Reductase: A Novel,Independent Prognostic Prognostic Marker In Patients With Hepatocellular Carcinoma
22.
Potential Use Of MicroRNA-200c As A Prognostic Marker In Non-small Cell Lung Cancer And The Target Genes That MicroRNA-200c Regulated
23.
Co-expression Of TIM-3 And CEACAM1 Promote T Cell Exhaustion In Colorectal Cancer Patients And Their Effects On The Function Of CD8~+ T Lymphocytes
24.
A Prognostic Role Of Ecto-5'-Nucleotidase(CD73) In Breast Cancer Patients
25.
Pretreatment Platelet-lymphocyte Ratio Is An Independent Significant Prognostic Marker In Advanced Pancreatic Cancer Patients Undergoing Gemcitabine-based Chemotherapy
26.
Expression Study Of Vimentin And Vimentin 2p In Acute Myeloid Leukemia
27.
Red Cell Distribution Width As A Prognostic Marker In Patients With Acute Exacerbations Of Chronic Obstructive Pulmonary Disease
28.
Circulating MiR-1826 In Plasma Correlates With Circulating Tumor Cells And Is A Prognostic Marker In Colorectal Cancer
29.
Clinicopathological Features And Outcomes Of Pancreatic Cancer/Hsa
c
irc
0
007564:A Novel Diagnostic And Prognostic Marker For Pancreatic Cancer
30.
Effect Of Pancreatic Stellate Cells Derived Exosomal Mir-21 On Migration Ability Of Pancreatic Cancer Cells And Study Of The Prognostic Marker SERP1 Of Pancreatic Cancer
31.
Study On The Prognosis Impact And Mechanism Of CREPT Expression In Non-small Cell Lung Cancer
32.
AHNAK2 Is A Novel Prognostic Marker And Oncogenic Protein For Clear Cell Renal Cell Carcinoma
33.
1 The Molecular Mechanism Of Wnt/?-catenin Pathway Interacting Long Noncoding RNA In Triple-Negative Breast Cancer Malignant Progression 2 Clinical Significance Of The B7-H4 As A Novel Prognostic Marker In Breast Cancer
34.
TROP2 Expression In Serous Ovarian Carcinoma And Its Effects On The Tumor Biological Behavior
35.
The Tumor-promoting Role Of CDCA5 In Bladder Cancer And Its Mechanism
36.
1.The Function And Mechanism Of Fibroblast-derived Insulin-like Growth Factor 2 Attenuating Anti-tumor Immunity By Promoting T Cell Exclusion 2.Feasibility Study Of Mirna Combined Signature As A Survival Prognostic Marker For Patients With Endometrial Can
37.
AUNIP:A Novel Diagnostic And Prognostic Marker In OSCC
38.
CD148 Serves As S Prognostic Marker Of Gastric Cancer And Hinders Tumor Progression By Dephosphorylating EGFR
39.
The Molecular Biomarker Roles Of Overexpression Paip1 In Gastric Cancer
40.
Systemic Immune-inflammation Index As A Prognostic Marker In Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma:A Propensity Score-matched Study
<<First
<Prev
Next>
Last>>
Jump to